Global Veterinary Antimicrobial Susceptibility Testing Market
Veterinary Healthcare

Veterinary Antimicrobial Susceptibility Testing Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Veterinary Antimicrobial Susceptibility Testing Market Growth Performance Trended Historically, And What Lies Ahead?#_x000D_

In recent years, there has been a significant increase in the size of the veterinary antimicrobial susceptibility testing market. The market, worth $37.12 billion in 2024, is projected to increase to $39.63 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%. The expansion during the historic period can be linked to factors such as environmental concerns, the demand for precision medicine, the one health approach, increased consumer awareness, and the growth of companion animal healthcare._x000D_

_x000D_

In the coming years, a robust expansion is anticipated in the veterinary antimicrobial susceptibility testing market, with predictions of reaching $53.66 billion by 2029, at a compound annual growth rate (CAGR) of 7.9%. The rise during the prognosis period can be credited to factors like controlling antibiotic resistance, regulatory guidelines, the effect of worldwide health incidents, and an increase in pet ownership. The forecast period will also witness several significant trends such as innovative approaches, regulatory focus, control of zoonotic diseases, and the standardization of the livestock industry._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=8177&type=smp_x000D_

_x000D_

#What External and Internal Drivers Are Contributing to the Growth of theVeterinary Antimicrobial Susceptibility Testing Market?#_x000D_

The growth of the veterinary antimicrobial susceptibility testing market is predicted to be driven by the increasing occurrence of zoonotic diseases. A zoonotic disease is an infectious disease that can transmit from one species of animal to another, including between humans and animals. The rise of such diseases necessitates the testing and identification of the most effective veterinary medication. Veterinary antimicrobial susceptibility testing is a tool used for selecting the ideal drug to treat bacterial diseases in animals, based on treatment history and more. For example, a US government agency reported in an article issued by the World Health Organization in July 2022 that zoonotic disease cases in Africa increased by 64%. Additionally, both globally and in India, occurrences of zoonotic diseases are rising. These emerging diseases in humans represent around 60% of cases, with 816 zoonotic pathogens contributing to 1407 human pathogens. Hence, the escalating frequency of zoonotic diseases is bolstering the expansion of the veterinary antimicrobial susceptibility testing market._x000D_

_x000D_

#What Segment Types Define the Veterinary Antimicrobial Susceptibility Testing Market Structure?#_x000D_

The veterinary antimicrobial susceptibility testing market covered in this report is segmented – _x000D_

_x000D_

1) By Product Type: Disks And Plates, Culture Media, Accessories And Consumables, Automated AST (Antimicrobial Susceptibility Test) Instruments _x000D_

2) By Animal Type: Livestock Animals, Companion Animals _x000D_

3) By End-Use: Veterinary Reference Lab, Veterinary Research Institutes, Other End-Users_x000D_

_x000D_

Subsegments:_x000D_

1) By Disks And Plates: Antibiotic Disks, Agar Plates_x000D_

2) By Culture Media: Selective Culture Media, General Purpose Media_x000D_

3) By Accessories And Consumables: Incubators, Sterilization Equipment, Pipettes And Reagents_x000D_

4) By Automated AST (Antimicrobial Susceptibility Test) Instruments: Fully Automated Systems, Semi-Automated Systems_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=8177&type=smp_x000D_

_x000D_

#Which Geographic Areas Hold the Strongest Growth Potential in the Veterinary Antimicrobial Susceptibility Testing Market?#_x000D_

North America was the largest region in the veterinary antimicrobial susceptibility testing market in 2024. The regions covered in the veterinary antimicrobial susceptibility testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Long-Term Trends Are Transforming the Competitive Landscape of the Veterinary Antimicrobial Susceptibility Testing Market?#_x000D_

The rising trend of technological advancements is greatly impacting the veterinary antimicrobial susceptibility testing market. The major players in the veterinary market are focused on developing innovative technologies to hold their market position. Recently, there has been an uptick in the utilization of cutting-edge imaging techniques and algorithms for veterinary AST (antimicrobial susceptibility testing) that provide more accuracy, reliability, and speed. In March 2022, bioMérieux, a biotech company based in France, obtained FDA 510(k) clearance for its new VITEK MS PRIME, MALDI-TOF1 type mass spectrometry identification system. With this FDA 510(k) clearance, the system is now commercially available in CE-mark recognizing countries, as well as in the United States. This system allows for rapid and accurate pathogen identification, thus providing faster and more precise antimicrobial therapy._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/veterinary-antimicrobial-susceptibility-testing-global-market-report_x000D_

_x000D_

#What Is the Definition of the Veterinary Antimicrobial Susceptibility Testing Market?#_x000D_

Veterinary antimicrobial susceptibility testing refers to a critical tool for the veterinarian in choosing the best drug to treat bacterial infections in animals. Veterinary antimicrobial susceptibility testing is used to provide a treatment history, including any previously used specific antibiotics as well as any clinical background that might have an impact on the patient’s typical bacterial flora. _x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8177_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model